The future development of Life Sciences ready facilities
There is a lot of excitement surrounding the booming Life Sciences sector, and the opportunity this presents for the UK property industry - but is it just hype?
In this paper, we set out to test the market by speaking to leading influencers that represent different facets of the SciTech real-estate industry. These conversations give a snapshot of how current requirements are being met, and how UK property might better service Life Sciences end-users in the future.
We have teamed up with Overbury to put together a series of interviews with the Life Sciences industry professionals to understand where the industry is heading and start the long-overdue conversation.
- Artem Korolev - Founder and Managing Director, Mission Street
- Peter Ward - Director of Real Estate Development, King’s College and Guy’s & St Thomas’
- Andrew Somerville - Partner, Head of Science & Research, Hoare Lea
- James Latham - Development and Leasing Director, Stevenage Bioscience Catalyst
- Peter Baird - Director of Urban Design, Perkins & Will
- Aaron Vernon - VP, Technical Operations, TCR²
What's it about?
There is a lot of excitement surrounding the booming Life Sciences sector, and the opportunity this presents for the UK property industry - but is it just hype?
In this paper, we set out to test the market by speaking to leading influencers that represent different facets of the Sci-Tech real-estate industry. These conversations give a snapshot of how current requirements are being met and how UK property might better service Life Sciences end-users in the future.
In this paper, we set out to test the market by speaking to leading influencers that represent different facets of the Sci-Tech real-estate industry. These conversations give a snapshot of how current requirements are being met and how UK property might better service Life Sciences end-users in the future.
Why are we doing this?
Life Sciences has grown exponentially in recent years, but we’re yet to see the pace of real estate growth that has taken place elsewhere. Could it be that the real-estate development market in the UK is underachieving? Are we off pace? Are the expectations too high? Or is it a reaction to the COVID-19 pandemic?
New treatments, therapeutics, and other new science sectors are blurring the boundaries between manufacturing and R&D. The rate of scientific progress has definitely changed but is construction keeping up?
With a diminishing certainty on returns from commercial development, traditional developers and institutional investors are looking at alternatives. The Sci-Tech sectors have become one such alternative, but without any dominant players in the market, there is room and opportunity to define standards and trends.
We hope you’ll enjoy reading this paper as much as we have collating it, and hope that it will encourage broader, deeper conversations to help us define the UK market identity.
Join us and the Life Sciences conversation on LinkedIn and Twitter. #LifeSciencesHype
New treatments, therapeutics, and other new science sectors are blurring the boundaries between manufacturing and R&D. The rate of scientific progress has definitely changed but is construction keeping up?
With a diminishing certainty on returns from commercial development, traditional developers and institutional investors are looking at alternatives. The Sci-Tech sectors have become one such alternative, but without any dominant players in the market, there is room and opportunity to define standards and trends.
We hope you’ll enjoy reading this paper as much as we have collating it, and hope that it will encourage broader, deeper conversations to help us define the UK market identity.
Join us and the Life Sciences conversation on LinkedIn and Twitter. #LifeSciencesHype
For this, and any other media enquiries, please get in touch at [email protected]
Download The future development of Life Sciences ready facilities